BIOMAT Database Logo BIOMAT Database Logo

Behçet's syndrome: treatment with recombinant leukocyte alpha-interferon. 1986

D Tsambaos, and D Eichelberg, and M Goos

UI MeSH Term Description Entries
D007370 Interferon Type I Interferon secreted by leukocytes, fibroblasts, or lymphoblasts in response to viruses or interferon inducers other than mitogens, antigens, or allo-antigens. They include alpha- and beta-interferons (INTERFERON-ALPHA and INTERFERON-BETA). Interferons Type I,Type I Interferon,Type I Interferons,Interferon, Type I,Interferons, Type I
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001528 Behcet Syndrome Rare chronic inflammatory disease involving the small blood vessels. It is of unknown etiology and characterized by mucocutaneous ulceration in the mouth and genital region and uveitis with hypopyon. The neuro-ocular form may cause blindness and death. SYNOVITIS; THROMBOPHLEBITIS; gastrointestinal ulcerations; RETINAL VASCULITIS; and OPTIC ATROPHY may occur as well. Behcet Disease,Behcet's Disease,Behcet's Syndrome,Triple-Symptom Complex,Adamantiades-Behcet Disease,Behcet Triple Symptom Complex,Behçet Disease,Old Silk Route Disease,Triple Symptom Complex,Adamantiades Behcet Disease,Adamantiades-Behcet Diseases,Behçet Diseases,Symptom Complex, Triple,Triple Symptom Complices

Related Publications

D Tsambaos, and D Eichelberg, and M Goos
[Behçet's syndrome: treatment with recombinant interferon gamma].
March 1990, Deutsche medizinische Wochenschrift (1946),
D Tsambaos, and D Eichelberg, and M Goos
Systemic interferon alpha 2b treatment in Behçet's syndrome.
June 1994, The Journal of rheumatology,
D Tsambaos, and D Eichelberg, and M Goos
[Treatment of hematological malignancies with recombinant leukocyte A interferon (rIFN-alpha A)].
December 1984, Gan to kagaku ryoho. Cancer & chemotherapy,
D Tsambaos, and D Eichelberg, and M Goos
Treatment of carcinoid syndrome with recombinant interferon alpha-2a.
January 1993, Acta oncologica (Stockholm, Sweden),
D Tsambaos, and D Eichelberg, and M Goos
Hemorrhagic fever with renal syndrome: treatment with recombinant alpha interferon.
May 1987, The Journal of infectious diseases,
D Tsambaos, and D Eichelberg, and M Goos
Interferon-alpha treatment of Behçet's disease.
October 1998, The Journal of rheumatology,
D Tsambaos, and D Eichelberg, and M Goos
Recombinant leukocyte alpha interferon in advanced ovarian carcinoma.
January 1985, Cancer treatment reports,
D Tsambaos, and D Eichelberg, and M Goos
Bovine peripheral blood leukocyte population dynamics following treatment with recombinant bovine interferon-alpha I1.
April 1989, Journal of interferon research,
D Tsambaos, and D Eichelberg, and M Goos
Effectiveness of leukocyte interferon-alpha treatment in patients with chronic hepatitis C not responsive to recombinant interferon.
October 1998, Digestive diseases and sciences,
D Tsambaos, and D Eichelberg, and M Goos
Anti-interferon alpha antibodies and autoantibodies in patients with Behçet's disease uveitis treated with recombinant human interferon alpha-2a.
March 2015, Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie,
Copied contents to your clipboard!